Farxiga vs Calquence
Side-by-side drug price comparison from Medicare Part D data
Verdict
Farxiga costs 97% less per claim than Calquence ($266.00 vs $10105.00). Farxiga has a generic alternative available. Total Medicare spending: Farxiga at $3.0B vs Calquence at $2.9B.
| Metric | Farxiga | Calquence |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $266* | $10,105 |
| Total Medicare Spending Total Medicare Part D spending on this drug | $3.0B | $2.9B |
| Total Claims | 11,240,000 | 286,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | 31.5%* | 34.2% |
| Generic Available | Yes | Yes |
| Condition | Diabetes | Cancer |
| Total Beneficiaries | 1,340,000 | 28,000 |
Farxiga costs 97% less per claim than Calquence ($266.00 vs $10105.00). Farxiga has a generic alternative available. Total Medicare spending: Farxiga at $3.0B vs Calquence at $2.9B.
Explore More
Comparing Farxiga and Calquence on U.S. Medicare prescription-drug pricing requires lining up the underlying CMS Medicare Part D Drug Spending data data side by side. The table above runs the comparison on the canonical fields; the narrative below identifies the factor or factors that drive the most meaningful difference between the two.
Practical use of the comparison: read the data above, then drill into the individual Farxiga and Calquence detail pages for the underlying breakdown. A pairwise comparison answers the relative question; the per-entity pages answer the absolute question.
Source: CMS Medicare Part D Spending, 2026.